Comparing the prognostic impacts of angiogenesis, lymphangiogenesis and lymphatic invasion (LI) in small cell lung carcinomas (SCLC)

G. Hardavella, E. Arkoumani, Y. Dalavanga, P. Galanis, D. Stefanou, S. Constantopoulos (Ioannina, Athens, Greece)

Source: Annual Congress 2008 - Management, quality aspects and prognosis in thoracic oncology
Session: Management, quality aspects and prognosis in thoracic oncology
Session type: E-Communication Session
Number: 1404
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Hardavella, E. Arkoumani, Y. Dalavanga, P. Galanis, D. Stefanou, S. Constantopoulos (Ioannina, Athens, Greece). Comparing the prognostic impacts of angiogenesis, lymphangiogenesis and lymphatic invasion (LI) in small cell lung carcinomas (SCLC). Eur Respir J 2008; 32: Suppl. 52, 1404

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic impact of lymphangiogenesis and lymphatic invasion (CD105 expression) in small cell lung carcinomas
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

Comparing LYVE-1 and D2-40 expression in small cell lung carcinomas (SCLC); association with clinical parameters and lymphatic invasion
Source: Annual Congress 2011 - Lung development and neoplasia
Year: 2011

Expression of vascular endothelial growth factor (VEGF) and association with lymphangiogenesis in non small cell (NSCLC) and small cell lung carcinomas (SCLC)
Source: Eur Respir J 2006; 28: Suppl. 50, 386s
Year: 2006

Expression of vascular endothelial growth factor (VEGF) and its receptors (VEFG-R1-Flt1, VEGF-R2-Flk1) in non small cell lung carcinomas (NSCLC): correlation with lymphangiogenesis and clinical outcome
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Distinct angiogenic and non-angiogenic growth patterns of lung metastases (LM) from renal cell carcinoma (RCC)
Source: Eur Respir J 2003; 22: Suppl. 45, 362s
Year: 2003

Espression of vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt1, VEGF-R2-Flk1) in non small cell (NSCLC) and small cell lung carcinomas (SCLC). Correlation with clinical outcome
Source: Annual Congress 2008 - Biology in thoracic tumours
Year: 2008


Vascular endothelial growth factor (VEGF) expression in non small cell lung cancer and its association with histopathologic type, stage, lymphnode involvement, recurrence and distant metastasis
Source: Eur Respir J 2003; 22: Suppl. 45, 393s
Year: 2003

Vascular endothelial growth factor (VEGF) and its receptors (VEGF-R1-Flt-1, VEGF-R2-KDR/Flk-1) as prognostic indicators in small cell lung carcinomas (SCLC)
Source: Annual Congress 2007 - Diagnosis and prognosis in thoracic oncology
Year: 2007


Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma
Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma
Year: 2006


Tumor-related angiogenesis: role in tumour growth and metastasis formation
Source: Annual Congress 2005 - Update on the role of angiogenesis in the pathogenesis and treatment of lung diseases
Year: 2005

Prognostic factors in pathological stage IB nonsmall cell lung cancer greater than 3 cm
Source: Eur Respir J 2010; 36: 1355-1361
Year: 2010



C-kit (CD 117): a new prognostic factor in small cell lung cancer (SCLC)
Source: Eur Respir J 2001; 18: Suppl. 33, 478s
Year: 2001

Apoptosis, tumor cell proliferation and angiogenesis as prognostic factor in lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 78s
Year: 2004

Composite anatomical–clinical–molecular prognostic model in nonsmall cell lung cancer
Source: Eur Respir J 2011; 37: 136-142
Year: 2011



Immunohistochemical study of intratumoral micro vessels in resected non-small cell lung carcinomas, N-status, pTNM-stage and survival period of the patients
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007


Prevalence of silent brain metastasis (BM) in the initial staging of non-small cell lung carcinoma (NSCLC)
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011


A novel biologic classification of non-small cell lung cancer
Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology
Year: 2005


A low endothelial cell proliferation fraction, a measurement of ongoing angiogenesis, is associated with poor prognosis in non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 763s
Year: 2006

Microscopic vessel invasion and visceral pleural invasion are correlated with EMT, cancer stemness and resistance to therapy in lung adenocarcinoma
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016

The risk of distant metastases and prognosis prediction in early stage squamous cell lung cancer (SqCLC) by means of 3 microRNAs expression assessment
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011